An analysis of sequencing data, including 13 independent studies and nearly 4000 patients (Table S1), showed that only 18 out of 3607 patients (0.5%) had one or more mutations in the SH2B3 gene (Figure 2a), suggesting that LNK mutations are not associated with breast cancer. The gene discussed is SH2B3; the disease is breast cancer.